Turner syndrome and GH treatment: The state of the art

Journal of Endocrinological Investigation

Volumn 27, Issue 11, 2004, Pages 1072-1075

  Pasquino, A M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Final height; GH treatment; Turner syndrome

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; AGE; BODY HEIGHT; CHILD; FEMALE; GENETICS; GROWTH DISORDER; HUMAN; MALE; PROGNOSIS; REVIEW; RISK FACTOR; TREATMENT OUTCOME; TURNER SYNDROME;

ADOLESCENT; AGE FACTORS; BODY HEIGHT; CHILD; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; MALE; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; TURNER SYNDROME;

EID: 15744404848     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03345312     Document Type: Review

References (41)

1. Lippe B. Turner syndrome. Endocrinol Metab Clin North Am 1991, 20: 121-52.
2. Saenger P. Turner syndrome. N Engl J Med 1996, 42: 90-4.
3. Hibi I, Tanae A, Tanaka T, Yoshizawa A, MiKi Y, Ito J. Spontaneous puberty in Turner syndrome: its incidence, influence on final height and endocrinological features. In: Ranke MB, Rosenfeld RG eds. Turner's syndrome and growth-promoting therapies. Amsterdam: excerpta Medica. 1991, 75-81.
4. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child 1985, 60: 932-5.
5. Ranke MB, Stubbe P, Majewski F, Bierich JR. Spontaneous growth in Turner's syndrome. Acta Paediatr Scand 1988, 343 (Suppl): 22-30.
6. Lippe BM, Plotnick L, Attie KM, Frane J. Growth in Turner syndrome: updating the United States experience. In: Hibi I, Takano K eds. Basic and clinical approach to Turner syndrome. Amsterdam: Elsevier. 1993, 77-82.
7. Bernasconi S, Larizza D, Benso L, et al. Turner's syndrome in Italy: familial characteristics, neonatal data, standards for birth weight and for height and weight from infancy to adulthood. Acta Paediatr 1994, 83: 292-8.
8. Rongen-Westerlaken C, Corel L, van den Broeck J, et al. Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment. Acta Paediatr 1997, 86: 937-42.
9. Sempé M, Hansson Bondallaz C, Limoni C. Growth curves in untreated Ullrich-Turner syndrome: French reference standards 1-22 years. Eur J Pediatr 1996, 155: 862-9.
10. Ranke MB, Blum WF, Haug F, et al. Growth hormone, somatomedin levels and growth regulation in patients with Turner's syndrome. Acta Endocrinol (Copenh) 1987, 116: 305-13.
11. Pasquino AM, Bernandini S, Cianfarani S, et al. GH assessment and three years hGH therapy in girls with Turner syndrome. Horm Res 1992, 38: 120-4.
12. Clement-Jones M, Schiller S, Rao E, et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000, 9: 695-702.
13. Belin V, Cusin V, Viot G, et al. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet 1998, 19: 67-9.
14. Binder G, Schwarze CP, Ranke MB. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone. J Clin Endocrinol Metab 2000, 85: 245-9.
15. Ellison JW, Wardach Z, Young MF, Gehron Robey P, Laig-Webster M, Chiong W. PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum Mol Genet 1997, 6: 1341-7.
16. Rosenfeld RG, Hintz RL, Johanson AJ, et al. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial. J Pediatr 1986, 109: 936-43.
17. Takano K, Hizuka N, Shizume K. Growth hormone treatment in Turner's syndrome. Acta Paediatr Scand (Suppl) 1986, 325: 58-63.
18. Carel JC, Mathivon L, Gendrel C, Ducret JP, Chaussain JL. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome. J Clin Endocrinol Metab 1998, 83: 1462-6.
19. Sas TC, de Muinck Keizer-Schrama SMPF, Stijnen T, et al. Normalization of height in girls with Turner syndrome after long term growth hormone treatment: results of a randomized dose-response trial. J Clin Endocrinol Metab 1999, 84: 4607-12.
20. Van Pareren YK, de Muinck Keizer-Schrama SM, Stijen T, et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low estrogens. J Clin Endocrinol Metab 2003, 88: 1119-25.
21. Massa G, Otten BJ, De Muinck Keizer-Schrama S, et al. Treatment with two growth hormone regimens in girls with Turner syndrome: final height results. Dutch Growth Hormone Working Group. Horm Res 1995, 43: 144-6.
22. Rochiccioli P, Battin J, Bertrand AM, et al. Final height in Turner syndrome patients treated with growth hormone. Horm Res 1995, 44: 172-6.
23. Takano K, Shizume K, Hibi I and the Committee for the treatment of Turner Syndrome. Long-term effects of growth hormone treatment on height in Turner syndrome: results of a 6-Year multicentre study in Japan. Horm Res 1995, 43: 141-3.
24. Tillmann V, Bucknall JL, Price DA, Clayton PE. Growth to final height in Turner syndrome factors predicting the response to growth hormone therapy. Horm Res 1995, 44 (Suppl 1): 279.
25. Van den Broeck J, Massa CG, Attanasio A, et al. Final height after long-term growth hormone treatment in Turner syndrome. European Study Group. J Pediatr 1995, 127: 729-35.
26. Haeusler G, Schmitt K, Blumel P, Plochl E, Waldhor Th, Frisch H. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height. Acta Paediatr, 85: 1408-14.
27. Nilsson KO, Albertsson-Wikland K, Alm J, et al. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab 1996, 81: 635-40.
28. Pasquino AM, Passeri F, Municchi G, et al. Final height in Turner syndrome patients treated with growth hormone. Horm Res 1996, 46: 269-72.
29. Taback SP, Collu R, Deal CL, et al. Does growth hormone supplementation affect adult height in Turner's syndrome? Lancet 1996, 348: 25-7.
30. Chu CE, Peterson WF, Kelnar CJ, Smail PJ, Greene SA, Donaldson MD. Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner's syndrome. Acta Paediatr 1997, 86: 160-4.
31. Plotnick L, Attie KM, Blethen SL, Sy JP. Growth hormone treatment of girls with Turner syndrome: the national cooperative growth study experience. Pediatrics 1998, 102: 479-81.
32. Rosenfeld RG, Attie KM, Frane J, et al. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 1998, 132: 319-24.
33. Cacciari E, Mazzanti L, and the Italian Study Group for Turner syndrome. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. J Clin Endocrinol Metab 1999; 84: 4510-5.
34. Hochberg Z, Zadik Z. Final height in young women with Turner syndrome after GH therapy: an open controlled study. Eur J Endocrinol 1999, 141: 218-24.
35. Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J and the Genentech. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. J Clin Endocrinol Metab 2000, 85: 2439-45.
36. Johnston DI, Betts P, Dunger D, et al. A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis. Arch Dis Child 2001, 84: 76-81.
37. Reiter EO, Blethen SL, Baptista J, Price L. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome. J Clin Endocrinol Metab 2001, 86: 1936-41.
38. Quigley CA, Crowe BJ, Anglin DG, Chipman JJ, and the US Turner syndrome study group. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 2002, 87: 2033-41.
39. Ranke MB, Partsch CJ., Lindberg A, et al. Follow-up study. Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU follow-up study. 2001. Eur J Endocrinol 2002, 147: 625-33.
40. Massa G, Heinrichs C, Verlinde S, et al., in collaboration with the Belgian study group for Paediatric Endocrinology. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height. J Clin Endocrinol Metab 2003, 88: 4168-74.
41. Ranke M, Linberg A, Chatelain P, et al. and KIGS International Board. Kabi International Growth Study. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. J Clin Endocrinol Metab 2000, 85: 4212-8.